AI assistant
PROCEPT BioRobotics Corp — Director's Dealing 2022
Jun 23, 2022
31665_dirs_2022-06-22_1268792b-ae3d-480e-bb09-63430f8292da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2022-06-21
Reporting Person: Krummel Thomas M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-21 | Common Stock | M | 10477 | $1.33 | Acquired | 93397 | Direct |
| 2022-06-21 | Common Stock | M | 6834 | $4.5125 | Acquired | 100231 | Direct |
| 2022-06-22 | Common Stock | M | 2689 | $4.5125 | Acquired | 102920 | Direct |
| 2022-06-21 | Common Stock | S | 10477 | $36.1352 | Disposed | 92443 | Direct |
| 2022-06-21 | Common Stock | S | 6834 | $36.1352 | Disposed | 85609 | Direct |
| 2022-06-21 | Common Stock | S | 2689 | $35.0007 | Disposed | 82920 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-21 | Stock Option (Right to Buy) | $1.33 | M | 10477 | Disposed | 2025-09-18 | Common Stock (10477.0) | Direct |
| 2022-06-21 | Stock Option (Right to Buy) | $4.5125 | M | 6834 | Disposed | 2028-04-26 | Common Stock (6834.0) | Direct |
| 2022-06-22 | Stock Option (Right to Buy) | $4.5125 | M | 2689 | Disposed | 2028-04-26 | Common Stock (2689.0) | Direct |
Footnotes
F1: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $38.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $38.15.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01.
F5: The option is fully vested and exercisable.